InvestorsHub Logo
Followers 20
Posts 1931
Boards Moderated 0
Alias Born 08/29/2018

Re: RobotDroid post# 677267

Friday, 03/08/2024 10:41:38 AM

Friday, March 08, 2024 10:41:38 AM

Post# of 689599
To think anyone could question DCVax-L approval when an approved drug got this after approval.

The $158,000-a-year treatment for the paralyzing nerve disease gained full Food and Drug Administration approval in 2022 despite uncertainty about its effectiveness. Amylyx officials will discuss the results with regulators and patients over the next eight weeks, including the possibility of voluntarily removing the drug from the market, the company said Friday in a statement. 
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News